Katherine Goodrich - 13 Nov 2024 Form 3 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Director
Signature
/s/ Scott Sieckert, Attorney-in-Fact
Issuer symbol
TARS
Transactions as of
13 Nov 2024
Net transactions value
$0
Form type
3
Filing time
15 Nov 2024, 16:36:17 UTC
Next filing
16 Jun 2025

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney